Breaking News Instant updates and real-time market news.

AAL

American Airlines

$16.40 /

-0.02 (-0.12%)

, DAL

Delta Air Lines

$38.39 /

+0.5 (+1.32%)

10:55
01/25/22
01/25
10:55
01/25/22
10:55

Redburn more cautious on U.S. airlines, downgrades American to Neutral

Redburn analyst James Goodall earlier today downgraded American Airlines (AAL) to Neutral from Buy with an $18 fair value estimate. The analyst also kept a Neutral rating on Delta Air Lines (DAL) with a $38 fair value estimate and Sell rating on United Airlines (UAL) with a $35 fair value. The continued delay in the air travel recovery due to the omicron variant "is taking its toll," Goodall tells investors in a research note. The analyst says "higher costs and weak revenues will impact the already sensitive financial positions" of the U.S. airlines over the coming quarters. He now expects all the network airlines will see negative free cash flow and rising net debt this year. This leaves Goodall more cautious on the U.S. Airlines. Lower capacity and increased disruption will leave costs inflated through the first half of the year, predicts the analyst. When coupled with reduced revenue expectations as both international and business travel "stagnate," both American and United will see negative earnings this year, Goodall contends.

AAL

American Airlines

$16.40 /

-0.02 (-0.12%)

DAL

Delta Air Lines

$38.39 /

+0.5 (+1.32%)

UAL

United Airlines

$41.76 /

+0.36 (+0.87%)

OTHER BREAKING NEWS FROM THE FLY

Upgrade
Motorola Solutions assumed at Overweight from Equal Weight at Morgan Stanley » 06:47
05/23/22
05/23
06:47
05/23/22
06:47
MSI

Motorola Solutions

$210.37 /

-0.035 (-0.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

06:43 Today Morgan Stanley
Motorola Solutions upgraded to Overweight from Equal Weight at Morgan Stanley
05/09/22 Credit Suisse
Credit Suisse starts Axon at Outperform with $169 price target
05/09/22 Credit Suisse
Credit Suisse starts Tyler Technologies at Neutral with $408 price target
04/25/22 Loop Capital
Motorola Solutions initiated with a Buy at Loop Capital
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

Downgrade
Covetrus downgraded to Market Perform from Outperform at Raymond James » 06:46
05/23/22
05/23
06:46
05/23/22
06:46
CVET

Covetrus

$19.68 /

+1.65 (+9.15%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$19.68 /

+1.65 (+9.15%)

CVET Covetrus
$19.68 /

+1.65 (+9.15%)

05/09/22 Barclays
Covetrus price target lowered to $26 from $38 at Barclays
01/12/22 Goldman Sachs
Covetrus' 2022 Rx revenue outlook may be disappointing, says Goldman Sachs
11/18/21 Morgan Stanley
Covetrus initiated with an Equal Weight at Morgan Stanley
08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
CVET Covetrus
$19.68 /

+1.65 (+9.15%)

CVET Covetrus
$19.68 /

+1.65 (+9.15%)

Initiation
Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink » 06:45
05/23/22
05/23
06:45
05/23/22
06:45
VRTX

Vertex Pharmaceuticals

$258.71 /

+3.265 (+1.28%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird
05/06/22 Piper Sandler
Vertex Pharmaceuticals price target lowered to $242 from $249 at Piper Sandler
VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

Recommendations
Nio could be back to pre-shutdown levels by June, says Mizuho » 06:45
05/23/22
05/23
06:45
05/23/22
06:45
NIO

Nio

$16.44 /

-0.23 (-1.38%)

, TSLA

Tesla

$664.10 /

-45.39 (-6.40%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

05/16/22 BofA
Nio upgraded to Buy at BofA on 'brighter' second half view
05/16/22 BofA
Nio upgraded to Buy from Neutral at BofA
05/02/22 Morgan Stanley
Nio's April sales 'crimped' by lockdowns, says Morgan Stanley
04/13/22 Nomura
Nio production halt limited to weekends, says Nomura
TSLA Tesla
$664.10 /

-45.39 (-6.40%)

05/19/22 Wedbush
Tesla price target lowered to $1,000 from $1,400 at Wedbush
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/18/22 Piper Sandler
Tesla price target lowered to $1,035 from $1,260 at Piper Sandler
05/17/22 Tudor Pickering
Tesla upgraded to Hold from Sell at Tudor Pickering
NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

Upgrade
Trimble upgraded to Equal Weight from Underweight at Morgan Stanley » 06:43
05/23/22
05/23
06:43
05/23/22
06:43
TRMB

Trimble

$65.24 /

+0.16 (+0.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$65.24 /

+0.16 (+0.25%)

TRMB Trimble
$65.24 /

+0.16 (+0.25%)

05/06/22 Baird
Trimble price target lowered to $80 from $90 at Baird
03/28/22 JPMorgan
Trimble price target lowered to $77 from $79 at JPMorgan
10/14/21 Piper Sandler
Trimble initiated with Overweight on digitization at Piper Sandler
10/14/21 Piper Sandler
Trimble initiated with an Overweight at Piper Sandler
TRMB Trimble
$65.24 /

+0.16 (+0.25%)

Initiation
Theravance Biopharma initiated with an Outperform at SVB Leerink » 06:43
05/23/22
05/23
06:43
05/23/22
06:43
TBPH

Theravance Biopharma

$8.74 /

-0.09 (-1.02%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

02/24/22 H.C. Wainwright
Theravance Biopharma price target raised to $12 from $8 at H.C. Wainwright
11/05/21 JPMorgan
Theravance Biopharma upgraded to Neutral from Underweight at JPMorgan
09/16/21 Baird
Theravance Biopharma price target lowered to $7 from $10 at Baird
09/16/21 H.C. Wainwright
Theravance price target lowered to $8 from $21 at H.C. Wainwright
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

  • 25
    Jun
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

Upgrade
Motorola Solutions upgraded to Overweight from Equal Weight at Morgan Stanley » 06:43
05/23/22
05/23
06:43
05/23/22
06:43
MSI

Motorola Solutions

$210.37 /

-0.035 (-0.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

05/09/22 Credit Suisse
Credit Suisse starts Axon at Outperform with $169 price target
05/09/22 Credit Suisse
Credit Suisse starts Tyler Technologies at Neutral with $408 price target
04/25/22 Loop Capital
Motorola Solutions initiated with a Buy at Loop Capital
02/10/22 Credit Suisse
Motorola Solutions price target lowered to $288 from $306 at Credit Suisse
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

Downgrade
Axon downgraded to Equal Weight from Overweight at Morgan Stanley » 06:42
05/23/22
05/23
06:42
05/23/22
06:42
AXON

Axon

$99.50 /

+1 (+1.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXON Axon
$99.50 /

+1 (+1.02%)

AXON Axon
$99.50 /

+1 (+1.02%)

05/16/22 Baird
Baird downgrades three cloud stocks on focus shift to cash flows
05/12/22 Northland
Axon price target lowered to $130 from $180 at Northland
05/11/22 Baird
Axon price target lowered to $125 from $145 at Baird
05/09/22 Credit Suisse
Credit Suisse starts Axon at Outperform with $169 price target
AXON Axon
$99.50 /

+1 (+1.02%)

AXON Axon
$99.50 /

+1 (+1.02%)

Initiation
Roivant Sciences initiated with an Outperform at SVB Leerink » 06:42
05/23/22
05/23
06:42
05/23/22
06:42
ROIV

Roivant Sciences

$3.72 /

+0.075 (+2.06%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/08/21 H.C. Wainwright
Roivant Sciences initiated with a Buy at H.C. Wainwright
ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

Conference/Events
United Fire Group management to meet with Piper Sandler » 06:42
05/23/22
05/23
06:42
05/23/22
06:42
UFCS

United Fire Group

$29.42 /

-1.13 (-3.70%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

03/21/22 Piper Sandler
United Fire Group price target raised to $37 from $30 at Piper Sandler
12/01/21 Piper Sandler
United Fire Group upgraded to Overweight from Neutral at Piper Sandler
07/09/21 Piper Sandler
United Fire Group price target lowered to $28 from $35 at Piper Sandler
06/28/21 Sidoti
United Fire Group upgraded to Buy from Neutral at Sidoti
UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

Upgrade
Zebra Technologies upgraded to Equal Weight from Underweight at Morgan Stanley » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
ZBRA

Zebra Technologies

$325.57 /

+0.995 (+0.31%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

05/04/22 Needham
Zebra Technologies price target lowered to $500 from $535 at Needham
05/04/22 Baird
Zebra Technologies price target lowered to $440 from $550 at Baird
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
04/12/22 Morgan Stanley
Zebra Technologies price target lowered to $400 from $470 at Morgan Stanley
ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

Initiation
Alteryx initiated with an Outperform at FBN Securities » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
AYX

Alteryx

$55.68 /

+0.16 (+0.29%)

FBN Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

05/04/22 Loop Capital
Alteryx price target raised to $67 from $60 at Loop Capital
05/04/22 Cowen
Alteryx price target raised to $90 from $75 at Cowen
05/04/22 Citi
Alteryx price target raised to $95 from $86 at Citi
04/01/22 Needham
Alteryx price target raised to $86 from $66 at Needham
AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

Recommendations
April delinquency trends promising for Affirm, says Mizuho » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
AFRM

Affirm

/

+

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFRM Affirm
/

+

AFRM Affirm
/

+

05/17/22 Mizuho
Affirm price target lowered to $50 from $79 at Mizuho
05/16/22 Barclays
Affirm price target lowered to $35 from $65 at Barclays
05/13/22 RBC Capital
Affirm price target lowered to $48 from $58 at RBC Capital
05/13/22 Morgan Stanley
Affirm results reassuring, investors likely still cautious, says Morgan Stanley
AFRM Affirm
/

+

AFRM Affirm
/

+

AFRM Affirm
/

+

AFRM Affirm
/

+

Downgrade
Frontdoor downgraded to Hold from Buy at Truist » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
FTDR

Frontdoor

$26.45 /

+0.245 (+0.94%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

05/06/22 Truist
Frontdoor price target lowered to $32 from $50 at Truist
05/06/22 Raymond James
Frontdoor price target lowered to $31 from $40 at Raymond James
05/06/22 Oppenheimer
Frontdoor price target lowered to $34 from $41 at Oppenheimer
01/06/22 Goldman Sachs
Frontdoor assumed with a Neutral at Goldman Sachs
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

Conference/Events
Timken management to meet with Loop Capital » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
TKR

Timken

$57.88 /

-0.735 (-1.25%)

Meetings to be held in CA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TKR Timken
$57.88 /

-0.735 (-1.25%)

TKR Timken
$57.88 /

-0.735 (-1.25%)

05/03/22 KeyBanc
Timken price target lowered to $75 from $84 at KeyBanc
04/13/22 Oppenheimer
Timken initiated with an Outperform at Oppenheimer
02/15/22 Evercore ISI
Timken upgraded to Outperform at Evercore ISI on relative valuation
02/15/22 Evercore ISI
Oshkosh downgraded to In Line at Evercore ISI on relative valuation
TKR Timken
$57.88 /

-0.735 (-1.25%)

Upgrade
TreeHouse upgraded to Buy from Hold at Truist » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
THS

TreeHouse

/

+

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THS TreeHouse
/

+

THS TreeHouse
/

+

03/22/22 Truist
TreeHouse price target lowered to $35 from $40 at Truist
THS TreeHouse
/

+

THS TreeHouse
/

+

Initiation
Upwork initiated with a Sector Perform at RBC Capital » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
UPWK

Upwork

$18.32 /

+0.24 (+1.33%)

, MSFT

Microsoft

$252.57 /

-0.44 (-0.17%)

RBC Capital analyst Brad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

05/17/22 Piper Sandler
'Interesting time' to be looking at Upwork story, says Piper Sandler
05/16/22 Stifel
Upwork downgraded to Hold from Buy at Stifel
04/28/22 Needham
Upwork price target lowered to $33 from $42 at Needham
04/28/22 Canaccord
Upwork price target lowered to $36 from $40 at Canaccord
MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

05/19/22 RBC Capital
Microsoft investor meetings indicate no change to macro/demand, says RBC Capital
05/13/22 Tigress Financial
Microsoft pullback 'major buying opportunity,' says Tigress Financial
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
04/29/22 OTR Global
Okta view downgraded to Negative from Mixed at OTR Global
UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

Initiation
Radius Health initiated with a Market Perform at SVB Leerink » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
RDUS

Radius Health

$6.25 /

+0.41 (+7.03%)

, AMGN

Amgen

$247.42 /

+2.48 (+1.01%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

12/23/21 Stifel
New Radius' Tymlos label offers slight expansion potential, says Stifel
12/10/21 Morgan Stanley
Radius Health downgraded to Underweight from Equal Weight at Morgan Stanley
12/09/21 Goldman Sachs
Radius Health downgraded to Neutral from Buy at Goldman Sachs
12/09/21 H.C. Wainwright
Radius Health price target lowered to $10 from $23 at H.C. Wainwright
AMGN Amgen
$247.42 /

+2.48 (+1.01%)

06:20 Today SVB Leerink
Amgen initiated with a Market Perform at SVB Leerink
05/10/22 Mizuho
Amgen price target raised to $208 from $202 at Mizuho
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
04/28/22 BMO Capital
Amgen price target lowered to $243 from $263 at BMO Capital
RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

Hot Stocks
American Vanguard issues stockholder letter in support of director nominees » 06:38
05/23/22
05/23
06:38
05/23/22
06:38
AVD

American Vanguard

$22.31 /

-0.52 (-2.28%)

American Vanguard sent a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVD American Vanguard
$22.31 /

-0.52 (-2.28%)

Initiation
Pfizer initiated with a Market Perform at SVB Leerink » 06:38
05/23/22
05/23
06:38
05/23/22
06:38
PFE

Pfizer

$52.46 /

+1.805 (+3.56%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

Hot Stocks
Ocugen: FDA removes clinical hold on Phase 2/3 clinical trial for COVAXIN » 06:37
05/23/22
05/23
06:37
05/23/22
06:37
OCGN

Ocugen

$2.23 /

-0.01 (-0.45%)

Ocugen announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

05/08/22 Chardan
Chardan keeps Neutral on Ocugen, lowers price target to $3.50
04/18/22 Roth Capital
Roth views Ocugen getting rights in Mexico as 'great news'
03/29/22 Chardan
Ocugen price target lowered to $4 from $4.50 at Chardan
03/04/22 Roth Capital
Roth says EUA denial takes accelerated Covaxin paths in U.S. off table in 2022
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

  • 23
    Feb
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

Recommendations
Nvidia price target lowered to $280 from $350 at UBS » 06:37
05/23/22
05/23
06:37
05/23/22
06:37
NVDA

Nvidia

$167.18 /

-3.95 (-2.31%)

UBS analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

05/20/22 Wells Fargo
Nvidia price target lowered to $250 from $370 at Wells Fargo
05/20/22 Daiwa
Daiwa sees six month 'danger zone' for semiconductor stocks
05/19/22 Wedbush
Nvidia price target lowered to $190 from $300 at Wedbush
05/19/22 Oppenheimer
Nvidia price target lowered to $300 from $350 at Oppenheimer
NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

Initiation
Eli Lilly initiated with an Outperform at SVB Leerink » 06:36
05/23/22
05/23
06:36
05/23/22
06:36
LLY

Eli Lilly

$298.98 /

+12.43 (+4.34%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
05/02/22 Mizuho
Eli Lilly price target raised to $356 from $315 at Mizuho
04/29/22 Morgan Stanley
Eli Lilly price target raised to $369 from $364 at Morgan Stanley
04/29/22 Wells Fargo
Eli Lilly price target raised to $305 from $280 at Wells Fargo
LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

Downgrade
Sumitomo Pharma downgraded to Neutral from Buy at Citi » 06:36
05/23/22
05/23
06:36
05/23/22
06:36
DNPUF

Sumitomo Pharma

$9.69 /

+ (+0.00%)

Citi analyst Hidemaru…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNPUF Sumitomo Pharma
$9.69 /

+ (+0.00%)

08/16/21 Jefferies
Sumitomo Dainippon upgraded to Buy from Hold at Jefferies
06/14/21 Jefferies
Sumitomo Dainippon downgraded to Hold from Buy at Jefferies
Periodicals
Musk's planned takeover of Twitter creates 'chaos tax,' WSJ reports » 06:34
05/23/22
05/23
06:34
05/23/22
06:34
TWTR

Twitter

$38.28 /

+1 (+2.68%)

Within 24-hours,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

05/17/22 Wedbush
Tesla shares likely to be under pressure again Tuesday, says Wedbush
05/16/22 Wedbush
Bot issue likely excuse for lower Twitter price or Musk walks away, says Wedbush
05/16/22 Citi
Citi does not expect Twitter deal changes from spam review
05/13/22 Truist
Twitter, Musk deal could get 'messy' if he tries to walk away, says Truist
TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.